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Abstract 
 
 The aim of this study was to determine whether functional ecdysone 
response elements (EcREs) exist within the genome of Brugia malayi, a parasitic 
nematode that causes lymphatic filariasis. The hypothesis that EcREs exist in B. 
malayi stemmed from previous demonstration of a functional ecdysone response 
system in B. malayi (Tzertzinis et al., 2010). Real-time PCR (qPCR) experiments 
were conducted to measure gene expression levels for twelve genes proximal to 
five putative EcREs in 20-OH ecdysone treated and untreated B. malayi 
embryos. Seven genes showed consistent upregulation with 20-OH ecdysone 
treatment. Each of the five putative EcREs had at least one proximal gene 
consistently upregulated, suggesting that all five might be functional EcREs. One 
of the genes consistently upregulated in the qPCR experiments, Bm1_48650, 
codes for a MIZ zinc finger family protein, a likely transcription factor. Transgenic 
ecdysone induction assay experiments were conducted using embryos 
transiently transfected with a reporter construct driven by the EcRE-containing 
promoter of Bm1_48650. Significantly higher mean reporter gene activity (~3.5-
fold) was seen in 20-OH ecdysone treated versus untreated embryos. In another 
set of transgenic ecdysone induction assays, the EcRE motif in the Bm1_48650 
promoter was completely mutated, and this construct was tested in 20-OH 
ecdysone treated and untreated embryos. The mean reporter gene activity for 
 v 
the treated and untreated embryos transfected with the mutant constructs did not 
differ significantly from the untreated embryos transfected with the native EcRE-
containing promoter construct. These results showed that the EcRE in the 
promoter of Bm1_48650 is necessary for regulating gene expression in response 
to 20-OH ecdysone. This study substantiates previously discovered evidence of 
a functional ecdysone response system in B. malayi, which could potentially 
serve as a target for drug discovery for lymphatic filariasis. 
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Introduction 
 
Lymphatic filariasis is a neglected tropical disease caused by infection 
with parasitic filarial worms Brugia malayi, Brugia timori, and Wuchereria 
bancrofti. The disease can be extremely debilitating and greatly impact the lives 
of those afflicted with it. It is estimated that 120 million people are infected with at 
least one of these filarial species, and more than a billion people are at risk 
worldwide. Currently, lymphatic filariasis is endemic in 81 countries. W. bancrofti, 
responsible for approximately 90% of lymphatic filariasis infections, exists 
throughout tropical Asia, Africa, the Americas, and the Pacific. B. malayi 
accounts for the majority of the remaining infections, and like B. timori, is 
transmitted in east and south Asia (World Health Organization [WHO], 2010). 
Individuals are usually infected with lymphatic filarial parasites during 
childhood. As adults, many people never display clinical symptoms, but may 
experience lymphatic and kidney damage. Alternatively, individuals with long-
term chronic infections may suffer from lymphoedema (elephantiasis) of the arm, 
leg, scrotum, penis, vulva or breast; hydrocele (fluid build-up around the testes); 
as well as lymphatic and kidney damage. Of the roughly 40 million people living 
with these clinical pathologies, 15 million suffer from lymphoedema, whereas 25 
million men have urogenital swelling. Disease pathology is caused by blockage 
of the lymph system by the parasitic worms (WHO, 2000; WHO, 2010). 
 2 
Often, there is a social stigma attached to those with outward 
manifestations of the disease. This can limit chances of marriage and security of 
disfigured individuals. Additionally, as a result of physical limitations brought on 
by the disease pathology, those affected may be unable to work. This loss of 
ability to make a living perpetuates poverty already apparent in the areas where 
lymphatic filariasis is endemic. The physical and societal impacts of this disease 
warrant its status as a public health problem (WHO, 2000; WHO, 2010). 
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was 
established in 2000 by the World Health Organization (WHO) to facilitate 
elimination of lymphatic filariasis as a public health problem by 2020. The two 
main foci of the elimination strategy are transmission interruption and morbidity 
management. Mass drug administration (MDA) of two drugs to entire at-risk 
populations is the recommended approach for interrupting transmission. 
Currently, available drug treatments involve a single dose of albendazole with 
either ivermectin or diethylcarbamazine (DEC), administered once a year. The 
WHO (2010) recommends that this MDA regimen continue for at least five years. 
This is due to the fact adult worms, capable of producing millions of microfilariae, 
live for 4-6 years. Repeated treatments ensure microfilariae in patients’ blood 
have been cleared and maintained at a low enough level to prevent further 
transmission. Fortunately, manufacturers of albendazole and ivermectin have 
pledged donations of these pharmaceuticals to aid in treatment plans (Molyneux, 
Bradley, Hoerauf, Kyelem, & Taylor, 2003; WHO, 2010). Huge strides have been 
made in eliminating the lymphatic filariasis as a public health problem in the first 
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ten years of the GPELF’s existence. China and the Republic of Korea have 
officially been recognized for their achievement in eliminating their lymphatic 
filariasis problem. Over 2.8 billion doses of pharmaceuticals have been dispersed 
worldwide, covering 63% of the at-risk population (WHO, 2010). 
Although MDA programs have exhibited a decrease in rates of infection 
and disease, a number of problems and concerns exist with a limited selection of 
pharmaceutical treatments available to combat lymphatic filariasis. Existing drugs 
target either the larval stages or the parasites’ bacterial symbiont, Wolbachia, 
however, treatment of adult worms is believed necessary to improve results. 
Thus, discovery of targets in the adult stage is a priority for drug development 
(Kumar et al., 2007; McNulty, Weil, Heinz, Crosby, & Fischer, 2008; Scott & 
Ghedin, 2009). Without the ability to destroy or sterilize the adult worms, 
subsequent and continued infection with new microfilariae ensues, perpetuating 
the need for regular and repeated treatments (Scott & Ghedin, 2009). In addition, 
treatment choices are further limited in areas where Loa loa is also endemic, as 
people with high levels of microfilariae can experience adverse reactions with 
ivermectin treatment (WHO, 2010). Furthermore, appraisal of potential drug 
resistance is necessary to prevent a devastating setback due to possible 
development of parasite resistance to treatment (Williams, 2004). Some 
suggested filarial biological systems that may provide targets for drug therapies 
include the nervous and reproductive systems, cuticle formation, and the molting 
process. Interactions between B. malayi and its hosts rely on mechanisms 
integral to survival of the worm, and thus provide attractive drug targets (Scott & 
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Ghedin, 2009). Increasing the field of viable treatments with novel, efficient, and 
cost-effective therapies for treatment and prevention is thus an important 
research priority. 
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Background 
 
Research exploring the B. malayi genome began as part of the Filarial 
Genome Project (FGP), instituted by the WHO. The community of researchers 
that make up the Filarial Genome Project has made mapping the B. malayi 
genome, identifying genes, setting up data banks, and making these findings 
globally accessible the ultimate goal of their genomic investigations. Researchers 
chose B. malayi as the filarial model species based on a number of factors that 
facilitated working with these worms in laboratory studies. First, unlike W. 
bancrofti, B. malayi can be cultured in an animal host, and various life cycle 
stages are available for study. Furthermore, an added benefit exits in the 
availability of a B. malayi laboratory strain (Blaxter, Daub, Guiliano, Parkinson, & 
Whitton, 2002; Ghedin, Wang, Foster, & Slatko, 2004; Ghedin et al., 2007; Scott 
& Ghedin, 2009). Information garnered from research on B. malayi should be 
useful for study of other parasitic nematodes that may have homologous genes, 
regulatory systems, and biological pathways. 
A notable accomplishment of the FGP research endeavors was the 
sequencing of the B. malayi genome. B. malayi was the first sequenced parasitic 
nematode genome. Additionally, the FGP utilized expressed sequence tags 
(ESTs) from all phases of the parasite life cycle to identify and analyze 
expressed genes (Ghedin et al., 2007; Scott & Ghedin, 2009; Williams, 1999). 
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Possession of this backbone of information with regard to a pathogenic species 
sets the foundation for investigation of gene expression patterns and functional 
genomic research (Kumar et al., 2007). The knowledge gathered through 
subsequent genetic research involving gene function and regulation should allow 
scientists to pinpoint the most promising targets for treatment of infection with B. 
malayi. These drug targets may also exist in other filarial worm species and 
similar treatments could be useful in combating those infections as well. 
As a member of the superphylum Ecdysozoa, B. malayi go through the 
process of molting during their life cycle. Molting involves the shedding of the 
outer protective exoskeleton, or cuticle, after a new cuticle layer has formed to 
replace it. This process occurs four times in the development of the nematode 
worm (Kumar et al., 2007). Microfilariae living in the human bloodstream are 
taken up by a mosquito during a blood meal and molt twice into the L2 and L3 
larval stages in the mosquito vector. The L3, or third stage larvae, are infective to 
humans, and in the human host these larvae further develop to L4, and 
subsequently adults that eventually produce microfilariae (Dieterich & Sommer, 
2009). Each molt involves a complex set of events involving structural, metabolic, 
and behavioral changes (Craig, Isaac, & Brooks, 2007). Molting-associated 
genes and proteins make favorable targets as they are not found in humans or 
other vertebrates (Kumar et al., 2007). 
Ecdysone is a steroid hormone that drives developmental processes such 
as molting, metamorphosis, oogenesis, and embryogenesis in insects. An 
ecdysone response system, such as that found in fruit flies, Drosophila, is also 
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hypothesized to regulate the process of molting in filarial parasites. The 
ecdysone response system involves two nuclear receptor proteins that form a 
heterodimer and act as a receptor for the ecdysone hormone. In Drosophila, 
these hormone receptor proteins are ecdysone receptor protein (EcR) and 
ultraspiracle protein (USP), a homolog of the retinoid X receptor (RXR) 
(Tzertzinis et al., 2010). Nuclear receptors, induced by ligands such as 
ecdysone, regulate transcription of target genes by binding to hormone response 
elements present in the promoters of those genes (Perera et al., 2005). A 
number of genes discovered to be induced by 20-OH ecdysone, as direct targets 
of ECR/USP, are transcription factors (Gauhar et al., 2009) The activation of the 
initial target genes triggers a cascade of gene expression, ultimately facilitating 
the necessary physiologic and morphologic changes in the organism (Tzertzinis 
et al., 2010. 
Among the nuclear receptor family members identified in the B. malayi 
genome were a number of proteins similar to those that play a role in the 
Drosophila melanogaster ecdysone response system (Ghedin et al., 2007). 
Recently, both protein constituents of the ecdysone receptor were identified 
when B. malayi EcR (Bma-EcR) and RXR (Bma-rxr) homologues were 
successfully cloned. Furthermore, the Bma-EcR and Bma-rxr proteins were 
shown to form a heterodimer capable of driving gene expression in response to 
an ecdysteroid hormone. In addition, Bma-EcR partnered with Aedes aegypti 
USP (AaUSP) displayed binding with a synthetic palindromic ecdysone response 
element (EcRE), PAL-1. Together, these findings reveal the presence of an 
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ecdysone receptor which has the ability to bind EcRE DNA sequences, and 
activate transcription in response to ecdysteroids. This ultimately indicates the 
existence of an ecdysone signaling system that functions in B. malayi (Tzertzinis 
et al., 2010). Research into manipulation of the ecdysone signaling system could 
provide mechanisms for halting procession of the filarial life cycle, and potential 
therapeutics. 
Expression patterns of both Bma-EcR and Bma-rxr were studied for 
various life stages and Bma-EcR was found to be expressed in L1, L2, L3, and 
adult males and females, and Bma-rxr was expressed in L1, and adult males and 
females. The fact that both proteins were expressed in adult females provides 
evidence for the potential role that ecdysone plays in oogenesis and 
embryogenesis in B. malayi, as is does in insects (Tzertzinis et al., 2010; Wang, 
Miura, Miksicek, Segraves & Raikhel, 1998). 
A transgenic hormone induction assay was successful in demonstrating 
increased gene expression attributed to 20-OH ecdysone treatment in B. malayi. 
This assay incorporated a luciferase reporter vector containing 5 tandem repeats 
of a synthetic EcRE (PAL-1), and helped bolster the evidence for the existence of 
an ecdysone response system in B. malayi. The reporter vector was introduced 
into B. malayi embryos using biolistic transient transfection techniques (Tzertzinis 
et al., 2010). Biolistic transient transfection has been optimized for B. malayi and 
has provided a useful mechanism for transfer of DNA into these parasites 
(Higazi, Merriweather, Shu, Davis, & Unnasch, 2002). Biolistic transfection 
involves the firing of DNA that is precipitated onto heavy metal bead particles into 
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an organism’s cells. Varying methods, such as helium discharge, and water 
vaporization caused by high-voltage spark, are capable of providing the high 
pressure needed for particle acceleration (Villemejane & Mir, 2009). Transient 
transfection allows for examination of gene regulation in a native environment, 
avoiding potential difficulties in conclusively determining promoter activity in non-
native systems (Shu, Katholi, Higazi, & Unnasch, 2003). 
While almost all components of the ecdysone response system have been 
discovered in B. malayi, it is necessary to determine the existence of functional 
ecdysone response elements (ECREs) within the B. malayi genome. The 
presence of functional EcREs would show that this system not only exists in B. 
malayi, but has the regulatory component within the genome to control 
expression of necessary molting genes. Whereas there is some degree of 
consensus, the sequences and structures that ECREs display in insect and 
nematode species have been found to vary. Naturally, EcREs have asymmetric 
configurations, occurring as imperfect palindromes or direct repeats. The first 
functional EcRE was discovered in the Drosophila hsp27 promoter. This EcRE 
has an imperfect palindrome arrangement, with one nucleotide separating its two 
half-sites (GGTTCAATGCACT). Other functional EcREs in Drosophila have 
configurations similar to the hsp27 EcRE, yet some are direct repeats containing 
variable numbers of spacer nucleotides. In general, steroid hormone receptors 
bind to inverted repeats of (Pu)G(G/A)(T/A)CA hexameric core motif. The motif 
(Pu)G(G/T)TCA is a common half-site pattern in natural ecdysone response 
elements. Receptor binding experiments have demonstrated that insect 
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EcR/USP heterodimers can also bind to symmetrical (perfect) palindromes 
(Perera et al., 2005; Vogtli, Elke, Imhof, & Lezzi, 1998; Wang, Miura, Miksicek, 
Segraves, & Raikhel, 1998). 
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Materials and Methods 
 
Real-time PCR 
 
Real-time PCR (qPCR) assays were conducted to determine expression 
levels of twelve B. malayi genes in embryos exposed to 20-OH ecdysone. These 
twelve target genes were selected due to their close proximity to putative EcREs. 
Twenty adult female worms were dissected using a scalpel blade to 
isolate their embryos. Embryos from half of the worms were maintained in 10ml 
CF-RPMI embryo culture medium (RPMI tissue culture medium containing 25mM 
HEPES, 20% fetal calf serum, 20mM glucose, 24mM sodium bicarbonate, 2.5 
mg/ml amphotericin B, 10 U/ml penicillin, 10 U/ml streptomycin, and 40 mg/ml 
gentamicin) supplemented with 5uM 20-OH ecdysone dissolved in 50% ethanol. 
The remaining embryos were cultured in 10ml CF-RPMI supplemented with 
ethanol solvent. The embryos were incubated for 48 hours at 37ºC and 5% CO2, 
after which they were harvested. The harvested embryos were combined with 
1ml of Trizol reagent and were frozen at -80ºC. 
The embryo tissue in Trizol reagent was homogenized using a frozen 
mortar and pestle and transferred to a sterile microcentrifuge tube. For phase 
separation, 200 ul of chloroform was added, the mixture vortexed for 15 seconds, 
incubated at room temperature for 2-3 minutes, and centrifuged at 2-8ºC and 
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14,000 rpm for 15 minutes. The upper aqueous phase was transferred to a fresh 
tube and the RNA was precipitated by mixing with 500 ul isopropyl alcohol. The 
samples were incubated at -20ºC for 10 minutes, and centrifuged at 2-4ºC, 
14,000 rpm for 10 minutes. The RNA pellet was washed once with 1ml 70% 
ethanol, vortexed, and centrifuged at 15,000 rpm for 5 minutes. The ethanol 
wash procedure was repeated once again, and all ethanol removed. The RNA 
pellet was air-dried for 5-10 minutes and resuspended in 50uL sterile water. 
The BioRad IScript cDNA synthesis kit was used to synthesize cDNA from 
the isolated B. malayi RNA. Real-time PCR reactions of the cDNA were set up 
using iQ™ SYBR® Green supermix and were run in a Bio-Rad iCycler Thermal 
Cycler. Primer sets were designed specifically for each of the twelve target 
genes, as well as an endogenous control, ND4 NADH dehydrogenase. The 
Comparative CT Method (ΔΔ CT) was used for quantitation of the amount of the 
target. This quantitation method normalized the amount of target gene to the 
endogenous control gene, and the ecdysone-exposed target was measured 
relative to the unexposed target control. 
 
Ecdysteroid response reporter construct: BmRPS12-EcRE-rev 
 
An ecdysteroid response reporter construct, BmRPS12-EcRE-rev, 
previously shown to be responsive to 20-OH ecdysone treatment, was used in 
transient transfection control experiments run in parallel with the qPCR 
experiments. This construct included the reverse PAL-1 EcRE, a double stranded 
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oligonucleotide that consisted of five tandem repeats of the EcRE 
(GGACAAGGTCAGTGACCTCCTTGTTC), in a reverse orientation, inserted into 
the BmRPS12 promoter from which the endogenous repeat enhancer had been 
deleted, driving the expression of firefly luciferase in the promoterless vector 
pGL3 Basic. The control experiments tested promoter activity of the constructs in 
transiently transfected B. malayi embryos treated with 20-OH ecdysone. These 
control experiments were used to verify whether each set of embryos were 
responsive to the 5uM 20-OH ecdysone treatment (Tzertzinis et al. 2010). 
 
Construction of EcRE promoter reporter plasmid: Bm1_48650-EcRE 
 
First, PCR amplification with Taq polymerase high fidelity was performed 
using primers (5’-AAGCTTGTGTTATTTTAGGCGTTATCAAGTTG-3’ and 5’-
AAGCTTAGGAGACGTATAAGGATCTAAGACAAC-3’) that included HindIII 
restriction sites. The primers were designed to isolate the upstream promoter 
region of gene Bm1_48650 from B. malayi DNA. The PCR product was purified 
using the QIAquick PCR purification system. Following purification, dA-tailing of 
the PCR products was performed in order to ensure successful ligation into 
pCR®2.1 TA vectors. Following ligation of the promoter fragments into the TA 
vectors, XL10-Gold competent E. coli cells were transformed with the TA 
constructs, and spread on LB plates containing carbenicillin. TA constructs were 
isolated for sequencing with a PureYield™ Plasmid Miniprep kit. Qiagen 
Maxiprep protocol was used to for increased yield of TA constructs.   
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Restriction digestion reactions with HindIII were performed on 10ug of the 
TA vector constructs as well as pGL3-Basic firefly luciferase reporter vectors. 
SuperSAP™ Shrimp Alkaline Phosphatase was included in the pGL3-Basic 
vector digestion reaction to enable dephosphorylation, and was subsequently 
heat inactivated at 65ºC for 15 minutes. Phenol extraction and ethanol 
precipitation of the pGL3-Basic vector digestion product followed. The TA vector 
clone digestion products were run on a 1% agarose gel, and the EcRE promoter 
insert bands were removed and purified with the GeneCleanII gel purification kit. 
Ligation of the pGL3-Basic vector and the EcRE promoter insert using T4 
DNA ligase was successfully performed with 75 ng insert DNA and 35 ng vector 
DNA (2:1 insert-to-vector ratio), as well as with a 4:1 insert-to-vector ratio. The 
ligation product was then transformed into XL10 Gold cells and plated on LB agar 
containing carbenicillin. PureYield™ Plasmid Miniprep and Qiagen Maxiprep kits 
were used to isolate the pGL3-Basic constructs containing the EcRE promoter. 
 
Mutagenesis 
 
The GeneTailor™ site-directed mutagenesis system was used to mutate 
the EcRE portion of the promoter within the pGL3-Basic construct. The EcRE 
(AGGTCATTGACCT) was completely mutated using primers designed according 
to protocol specifications (5’-
GTTTATTTAATAAGAAGGAACATCTCAGAGTACGTCGACTTGAATGT -3’ and 
5’-TTCCTTCTTATTAAATAAACACTTTCTGCTA -3’). 
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Transgenic hormone induction assay 
 
A transgenic hormone induction assay was used to determine promoter 
activity with 20-OH ecdysone treatment. As described, gravid adult female B. 
malayi worms were dissected in order to isolate embryos. The embryos were 
biolistically transfected with pGL3-Basic luciferase reporter constructs. Following 
transfection, embryos were incubated for 48 hours in CF-RPMI media, with a 
subset of embryo samples treated with 5uM 20-OH ecdysone dissolved in 50% 
ethanol and the control subset treated with solely 50% ethanol solvent. Finally, 
promoter activity was measured with a Dual Luciferase assay. For each construct 
analyzed, multiple independent experiments were conducted, with triplicate 
transfections performed during each experiment (Shu, Katholi, Higazi, & 
Unnasch, 2003; Tzertzinis et al. 2010). 
 
Statistical analysis 
 
A Dunnett’s test was performed on the luciferase assay results to 
determine whether any differences in mean activity were statistically significant. 
Mean activity of each experimental group (ecdysone-exposed embryos with 
EcRE promoter, unexposed embryos with mutant promoter, ecdysone-exposed 
embryos with mutant promoter) was compared with mean activity of the control 
group (unexposed embryos with EcRE promoter). 
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Results 
 
Based on previous research findings that revealed a functional ecdysone 
response system in B. malayi, it was believed that functional ecdysone response 
elements (EcREs) would be present within the B. malayi genome (Tzertzinis et 
al., 2010). The aim of this study was to locate EcREs within the B. malayi 
genome and demonstrate their functionality as gene expression regulators in an 
ecdysone response system. In order to locate putative EcREs within the B. 
malayi genome, contig DNA segments ≥200 kilobases were searched with strict 
criteria that corresponded to naturally occurring EcRE sequences. These pattern 
criteria specified either a perfect or imperfect palindrome containing a half site 
(R)GGTCA, with a 0-1 nucleotide spacer between half-sites. Thirty-one different 
sequences were found, with 6 of them existing twice. In total, thirty-seven motifs 
were located that fit the search criteria. Of these, 10 motifs were not considered 
for further analysis because they lacked a spacer nucleotide between the 
palindrome half-sites. Five of the remaining putative EcREs were selected 
randomly for further study (motif sequences GGGTCAATGACTC, 
AGGTCATTGAACT, AGGTCATTGACCT, GGGTCAGTGACCT, 
AGGTCAGTGACAT). 
The first step to determine whether these sequences might serve as 
functional EcREs in B. malayi was to quantify expression levels of genes 
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proximal to the putative EcREs. This was accomplished by performing real-time 
quantitative PCR (qPCR) on cDNA synthesized from embryo RNA, and 
calculating fold-differences in gene expression of 20-OH ecdysone exposed 
embryos relative to untreated embryos. If the EcREs were a functional part of an 
ecdysone response system, nearby genes should be differentially expressed in 
embryos treated with 20-OH ecdysone as compared to untreated embryos. In 
total, twelve target genes located near the five EcREs, were studied. The 
locations of these genes varied relative to the five EcREs, with five upstream 
genes (one per EcRE), five downstream genes (one per EcRE), and two genes 
containing an EcRE within the gene. The open reading frames of the genes also 
varied in their distance from putative EcREs, ranging from zero to 8165 base 
pairs away. 
Transfection experiments were conducted in parallel with the qPCR 
experiments to verify that each set of embryos was responsive to the 5uM 20-OH 
ecdysone treatment. Embryos were transfected with BmRPS12-EcRE-rev, a 
luciferase reporter vector containing 5 tandem repeats of the PAL-1 EcRE in 
reverse orientation within an enhancer-less BmRPS12 promoter. This reporter 
construct had previously been used by Tzertzinis et al. (2010) to examine activity 
of an EcRE-containing promoter in response to 20-OH ecdysone treatment. This 
construct had exhibited significantly higher reporter gene expression in embryos 
treated with 20-OH ecdysone versus unexposed embryos (Tzertzinis et al., 
2010). Because this construct reliably produced differential activity levels in 20-
OH exposed versus unexposed embryos, it was used in the current study as an 
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indicator of 20-OH ecdysone responsiveness in the embryo population. 
Throughout the control experiments, the mean luciferase activity levels in the 20-
OH ecdysone treated embryos were significantly higher (approximately 2.4-fold) 
than those of the uninduced embryos (Figure 1). A Dunnett’s statistical test 
showed that the difference in mean activities seen between the treated and 
untreated embryos was statistically significant (p-value <0.0001). The differences 
in mean activity observed in these control experiments were similar to those 
obtained by Tzertzinis et al. (2010) with the same construct, and 1uM 20-OH 
ecdysone treatment. The 20-OH ecdysone triggered reporter gene activity seen 
in this subset of embryos indicated that the embryos used in the qPCR 
experiments should have been responsive to 20-OH ecdysone treatment. 
 
 
Figure 1. Mean activity of uninduced BmRPS12-EcRE-rev promoter and 20-OH 
ecdysone treated BmRPS12-EcRE-rev promoter, showing a significant increase in 
activity with 20-OH treatment. Bars represent mean activity relative to the uninduced 
BmRPS12-EcRE-rev promoter. Error bars are the standard deviations resulting from 
multiple independent transfections. The asterisk indicates statistically significant 
difference in activity levels of denoted promoter compared with the uninduced 
BmRPS12-EcRE-rev promoter (p ≤ 0.05, Dunnett’s test). 
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Seven of the twelve target genes were consistently upregulated when 
embryos were exposed to 20-OH ecdysone in all three repeats of the qPCR 
experiments. The remaining target genes showed inconsistency in differential 
expression across the three repeat experiments (Table 1). Neither relative 
location nor distance from an EcRE appeared to have an effect on the induction 
of the genes. All five of the EcREs had at least one nearby gene consistently 
upregulated. These results suggest that all five of these EcREs perform a 
functional role in ecdysone response and gene regulation. However, they do not 
appear to regulate all flanking genes. One of the consistently upregulated genes 
codes for a MIZ zinc finger family protein (Bm1_48650), and is located 
approximately 2 kilobase pairs downstream of an EcRE (AGGTCATTGACCT) 
(Figure 2). Zinc finger proteins have the ability to bind DNA and act as 
transcription factors. Because this gene biologically makes sense as a target for 
increased gene expression in the primary stage of an ecdysone cascade, it was 
chosen as the focus for further study. 
 20 
 
Table 1. Mean fold-change in gene expression levels of 20-OH ecdysone 
treated embryos relative to untreated embryos, for twelve genes proximal to 
putative EcREs in the B. malayi genome. Standard deviations result from 
three independent qPCR experiments. Genes in shaded cells showed 
consistent upregulation throughout the repeat experiments. The MIZ zinc 
finger family protein, chosen for further analysis, is highlighted. 
 
Gene Mean fold-change 
Standard 
deviation 
major facilitator superfamily protein Bm1_12830 4.66 3.85 
protein kinase domain containing 
protein Bm1_12835 2.14 1.22 
hypothetical protein Bm1_12840 1.34 2.76 
6 phosphogluconolactonase family 
protein Bm1_33900 3.04 1.61 
probable beta arrestin Bm1_33905 2.83 1.32 
probable NADH-ubiquinone 
oxidoreductase 20 kDa subunit Bm1_48645 1.13 2.31 
MIZ zinc family protein Bm1_48650 3.15 2.47 
hypothetical protein Bm1_52900 1.00 3.31 
hypothetical protein - MADF_DNA 
binding alcohol dehydrogenase 
transcription factor Myb/SANT like Bm1_52905 7.01 5.88 
60S ribosomal protein L35a Bm1_52910 2.12 3.37 
helix-loop-helix DNA binding 
domain containing protein Bm1_42880 3.65 2.00 
filarial antigen Av33 precursor Bm1_42885 1.93 3.51 
 
The qPCR results indicate that the five EcREs are functional, but to 
determine that the increased level of gene expression is actually being driven by 
the EcRE requires proof that the EcRE sequence alone is necessary to 
upregulate gene expression. A transgenic 20-OH ecdysone induction assay was 
used to examine activity of the EcRE-containing promoter of the Bm1_48650 
gene. Transfections with this promoter cloned into a luciferase reporter vector 
showed a significantly higher level of expression of the luciferase reporter gene 
(roughly 3.5-fold) in embryos treated with 20-OH ecdysone relative to uninduced 
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embryos (Figure 3). A statistical analysis comparing mean luciferase activities of 
the 20-OH ecdysone treated versus untreated embryos showed that the 
observed difference was statistically significant (p-value <0.0001, Dunnett’s). 
These results confirmed the qPCR results with regard to the EcRE in the 
Bm1_48650 promoter, by showing that this EcRE-containing promoter was 
capable of driving increased expression under 20-OH ecdysone treatment 
conditions. Conversely, this experiment revealed that 20-OH ecdysone was able 
to trigger an increase in transcription above the background transcriptional 
activity of this EcRE-containing construct. These results demonstrate that this 
promoter was able to upregulate gene expression in an ecdysone-responsive 
manner, and is therefore likely a viable part of a B. malayi ecdysone response 
system. However, it was necessary to remove the EcRE from the promoter in 
order to show that the EcRE alone is responsible for the observed gene 
regulation. The EcRE portion of the Bm1_48650 promoter within the luciferase 
reporter constructs was completely mutated (Figure 4), and the activity of the 
mutated promoter determined using the transgenic 20-OH ecdysone induction 
assay. Statistical analysis of the difference in mean activities between the 
uninduced native EcRE-containing construct and the uninduced mutant showed 
no statistically significant difference (p-value = 0.9946). Most importantly, there 
was no statistically significant difference between mean activities of the 
uninduced native EcRE-containing construct and the 20-OH ecdysone treated 
mutant (p-value = 1.0000). These results confirm that this EcRE sequence was in 
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fact necessary for the increase in gene expression displayed when embryos 
were treated with 20-OH ecdysone (Figure 5).
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Figure 2. Map showing locations of genes, including Bm1_48650 MIZ zinc finger family protein, relative to an EcRE. 
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Figure 3. Mean activity of uninduced native Bm1_48650 EcRE-containing promoter and 
20-OH ecdysone treated Bm1_48650 EcRE promoter, indicating a significant increase in 
activity occurring with 20-OH ecdysone treatment in an EcRE-containing promoter. Bars 
represent mean activity relative to the uninduced native Bm1_48650 EcRE promoter. 
Error bars are the standard deviations resulting from multiple independent transfections. 
The asterisk indicates statistically significant difference in activity levels of denoted 
promoter compared with the uninduced native Bm1_48650 EcRE promoter (p ≤ 0.05, 
Dunnett’s test). 
 
 
 
Figure 4. Sequence of Bm1_48650 promoter EcRE, and corresponding mutated 
sequence. 
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Figure 5. Mean activity of uninduced mutant promoter and 20-OH ecdysone treated 
mutant promoter. Bars represent mean activity relative to the uninduced native 
Bm1_48650 EcRE promoter. Error bars are the standard deviations resulting from 
multiple independent transfections. There was no significant difference in activity levels 
of the treated and uninduced mutant promoter compared with the uninduced native 
Bm1_48650 EcRE promoter. 
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Discussion 
 
The finding by Tzertzinis et al. (2010) describing the existence of a viable 
ecdysone response system in B. malayi led to the hypothesis that B. malayi has 
functional EcREs within its genome that regulate gene expression as part of this 
system. The results from this study conclusively demonstrated the existence of a 
B. malayi EcRE that was necessary for regulating gene expression in response 
to 20-OH ecdysone. In addition, qPCR results indicated that additional viable 
EcREs may exist in B. malayi. These findings provided further evidence to 
support the existence of a functional 20-OH ecdysone-inducible gene expression 
system in B. malayi. 
The EcRE located within the promoter of gene Bm1_48650 is functional 
and necessary for regulating gene expression with 20-OH ecdysone treatment. 
Furthermore, there is enough evidence to consider Bm1_48650 an “early” gene 
participant in a B. malayi ecdysone response cascade. The Bm1_48650 gene 
codes for a MIZ zinc finger family protein, and zinc finger proteins have the ability 
to bind DNA and act as transcription factors. As one of the initially activated 
proteins, it would have the capability of regulating another group of genes, 
through repression or activation, thus expanding the field of proteins involved in 
the response cascade. 
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The results of the qPCR showed variability in expression levels and fold-
differences between 20-OH ecdysone treated and untreated embryos across 
independent experiments. However, the results indicated functionality of each of 
the five putative EcREs examined, as at least one gene proximal to each of the 
five EcREs displayed consistent upregulation across the repeat experiments. 
Furthermore, the results from the transgenic ecdysone induction assay 
experiments verified the functionality of one of these EcREs, thus confirming the 
qPCR results for one of the five EcREs. The established transgenic hormone 
induction assay is recommended for verification of functionality of additional 
putative EcREs. 
It is feasible that a much larger number of possible EcREs exist within the 
B. malayi genome than were identified in this study. First, only a selection of 
potential EcREs that were initially located were included in the qPCR 
experiments. Furthermore, the search criteria to identify putative EcREs in B. 
malayi were fairly strict. By including only perfect and imperfect palindromic 
sequences, other naturally occurring motifs - direct repeat arrangements - were 
not considered. Moreover, with only a single mismatched nucleotide allowed, 
sequences having greater nucleotide variation would not have been included. 
Widening the search parameters and performing qPCR with genes nearby to 
additional putative EcREs could reveal a larger collection of functional motifs. 
Once the ecdysone response system’s initial targets have been identified, 
there are methods available that would facilitate the identification and description 
of an ecdysone response cascade hierarchy and pathways within B. malayi. In 
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insects, ecdysone is responsible for regulating critical processes throughout the 
life cycle, including oogenesis, embryogenesis, molting, and metamorphosis 
(Gauhar et al., 2009; Tzertzinis et al., 2010; Wang, Miura, Miksicek, Segraves & 
Raikhel, 1998). Based on evidence of a functional ecdysone response system, 
and expression of ecdysone receptor proteins in various life stages, including 
adult females, it can be hypothesized that ecdysone also controls aspects of 
reproduction and molting in B. malayi. Determination of which genes are induced 
by ecdysone, and the function of their encoded proteins, is needed to elucidate 
which aspects of the B. malayi life cycle ecdysone regulates. RNA interference 
(RNAi) experiments could target B. malayi genes homologous to those 
necessary for successful oogenesis, embryogenesis, and molting in organisms 
such as C. elegans and D. melanogaster. The results would indicate whether 
these genes were critical players in these processes and ultimately, survival of 
the B. malayi parasite (Ghedin et al., 2007). Real-time PCR (qPCR) could be 
used to measure expression of these critical genes in 20-OH ecdysone treated 
and untreated worms or embryos. If these genes were upregulated in the treated 
worms, this would suggest that 20-OH ecdysone regulates the processes these 
genes are essential to. Microarrays could be used to compare gene expression 
profiles for 20-OH ecdysone treated versus untreated worms. The results would 
reveal genes that are affected by 20-OH ecdysone, providing an overall picture of 
what genes are participating in the cascade. However, the results would lack an 
indication of the response hierarchy of the cascade. Further analysis of the 
upregulated genes using Gene Ontology (GO) terms and biological pathways 
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that are described for other organisms would aid in determining potential 
pathways regulated by ecdysone in B. malayi. Furthermore, a comparison of the 
upregulated genes with ESTs for each stage of the B. malayi life cycle would aid 
in determining which processes the ecdysone response system regulates, based 
on the affected stages of the parasite’s life. 
The existence of an ecdysone response system in B. malayi provides a 
desirable avenue for drug targets (Kumar et al., 2007; Tzertzinis et al., 2010). 
Because this system is fundamentally controlled by an ecdysteroid, it could also 
be manipulated by ecdysteroid agonists or antagonists. Transactivation 
experiments by Tzertzinis et al. (2010) showed that both Ponasterone-A (an 
ecdysteroid) and RSL1 (an ecdysteroid agonist) were able to activate the ligand 
binding domain of Bma_EcR, leading to reporter gene expression. This verifies 
that different ecdysteroid compounds, as well as an ecdysteroid agonist have the 
ability to activate the ecdysone response system in B. malayi (Tzertzinis et al., 
2010). By interfering with the ecdysone response cascade, molting, oogenesis, 
or embryogenesis processes could be arrested, interrupted, or advanced 
inappropriately, leading to death. In fact, there are currently compounds being 
used as insecticides that target ecdysone receptors in larval insect stages 
(Nakagawa & Henrich, 2009; Wheelock et al., 2006).  
A rapid and reliable screening system capable of detecting ecdysteroid 
agonists and antagonists was created using transformed silk moth (Bombyx 
mori) cells. It is a high-throughput reporter assay system that can be used for 
initial appraisal of natural plant extracts as well as synthetic compounds for 
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ecdysone agonistic or antagonistic properties. In addition, preferred chemical 
structural characteristics of agonist and antagonist binding can be determined 
and predicted through modeling methods such as Quantitative structure-activity 
relationship (QSAR) and Comparative Molecular Field Analysis (CoMFA). 
(Swevers et al., 2004; Wheelock et al., 2006). Active agonist and antagonist 
compounds identified by the high-throughput assay can be tested for activity in a 
native B. malayi environment using the transgenic induction assay initially 
described and recommended in Tzertzinis et al. (2010). In experiments with 
putative agonists, treatment of the embryos with 20-OH ecdysone would be 
replaced by treatment of the embryos with the agonist compound. Whereas, 
testing of antagonistic compounds would involve concurrent treatment of the 
embryos with both the putative antagonist and 20-OH ecdysone. 
In conclusion, this study’s findings show that B. malayi has a functional 
EcRE within its genome. The EcRE was considered necessary for increased 
transcriptional activity seen with 20-OH ecdysone treatment. This functional 
EcRE sits within the promoter region of the Bm1_48650 gene, suggesting that 
this gene, which codes for a transcription factor, may act as a regulator as part of 
a signaling cascade. Furthermore, the findings from qPCR experiments indicate 
that B. malayi may have additional functional EcREs. The results from this study 
provide further validation of the existence of an ecdysone response system in B. 
malayi. Future work is necessary to determine whether the ecdysone response 
system controls any vital processes within this parasite. If so, the ecdysone 
response system would make for a promising target for drug development. The 
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lack of ecdysone receptors in humans substantiates this system’s practicality as 
a drug target (Wheelock et al., 2006). Moreover, availability of mechanisms for 
screening potential compounds for their ability to disrupt the ecdysone response 
system may allow for expeditious discovery of drugs capable of combating 
lymphatic filariasis. 
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